A New Approach to Undetectable Ovarian Cancer

Author: Amir Jazaeri, MD
Fact checked by: Sabrina Serani
August 23, 2025

Amir Jazaeri, MD, of MD Anderson Cancer Center, provides an in-depth perspective on the complex challenges of treating ovarian cancer. He explains that a majority of patients are diagnosed with advanced-stage disease, meaning the cancer has already spread extensively throughout the abdomen and possibly to other parts of the body. Despite this initial widespread nature, a combination of radical surgery and six cycles of platinum-based chemotherapy is often highly effective, leading to a state of remission where patients are considered cancer-free.

Read More at Targeted Oncology

UPDATES AND NEWS

Media Coverage

Clues to Why a Breakthrough Pancreatic Cancer Drug Eventually Stops Working | The New York Times

Media Coverage

We can prevent ovarian cancer. Women deserve the option. | USA Today

Media Coverage

Fallopian tube removal may lower ovarian cancer risk | Good Morning America

Press Release

The Lustgarten Foundation and Break Through Cancer Announce New Clinical Trial Evaluating KRAS-targeted Immunotherapy Strategy for Pancreatic Cancer

BE PART OF THE MISSION
Stay Informed, Make an Impact

Subscribe

Be the first to hear about cutting-edge research, pioneering projects, and the latest advancements in Break Through Cancer science. Sign up to stay informed.

* indicates required
Email Format

Give

Your contribution fuels groundbreaking research in some of the most challenging cancers. Every gift accelerates progress. For more information please contact Michaela Forand at MF@breakthroughcancer.org or 1-800-757-9881 ext 2.

Media Coverage